Antibiotic Strategy for Ventilator-Associated Respiratory Infections

A special issue of Antibiotics (ISSN 2079-6382). This special issue belongs to the section "Antibiotic Therapy in Infectious Diseases".

Deadline for manuscript submissions: 30 June 2026 | Viewed by 150

Special Issue Editor


E-Mail Website
Guest Editor
Department of Intensive Care Medicine, University Hospital Clínico San Carlos, 28040 Madrid, Spain
Interests: sepsis; septic shock; acute respiratory distress syndrome; pneumonia; usefulness of new rapid diagnostic respiratory tests

Special Issue Information

Dear Colleagues,

Ventilator-associated lower respiratory tract (LRT) infections continue to pose a significant clinical and research challenge in intensive care medicine. Ventilator-associated pneumonia (VAP) remains one of the most serious nosocomial infections in critically ill patients, associated with prolonged mechanical ventilation, longer hospital stays, higher healthcare costs, and excess mortality. Despite advances in preventive measures, significant knowledge gaps persist regarding optimal diagnosis, the utility of new molecular diagnostic tests, the role of risk factors and prior colonization in selecting the best empirical treatment, and the importance of preserving anaerobic flora in its management whenever possible.

Referring to ventilator-associated tracheobronchitis (VAT), its clinical relevance, impact on outcomes, and the indication for antibiotic treatment remain subjects of ongoing debate. The overlap of clinical and microbiological criteria between VAT and VAP further complicates bedside decision-making. Although biomarkers, such as procalcitonin, have been proposed to guide diagnosis and therapy, available evidence suggests that their ability to clearly discriminate between VAT, VAP, and colonization is limited.

In both cases, the increase in multidrug-resistant microorganisms makes it especially difficult to adjust the duration of treatment and to know whether the combination of two or more antibiotics improves the results or not.

We invite researchers and clinicians to submit original research articles, systematic reviews, and translational or methodological studies addressing ventilator-associated respiratory infections in critically ill patients.

Dr. Fernando Martínez-Sagasti
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Antibiotics is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • ventilator-associated pneumonia
  • ventilator-associated tracheobronchitis
  • biomarkers
  • antimicrobial stewardship
  • rapid diagnostic tests
  • multidrug-resistant microorganisms
  • difficult-to-treat microorganisms
  • combined antibiotic treatment

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

Further information on MDPI's Special Issue policies can be found here.

Published Papers

This special issue is now open for submission.
Back to TopTop